End-stage Renal Failure Patients Research Articles

#2607 Generation of a tissue resident macrophage depleted reporter rat to examine cardiovascular homeostasis and kidney disease

Abstract Cardiovascular disease (CVD) and chronic kidney disease (CKD) are currently the 1st and 10th leading cause of global mortality, respectively. By 2050, CKD is predicted to be the 5th leading cause, with most of those individuals dying of CVD. Recent single cell RNA sequencing data has highlighted the plasticity of macrophage populations in both renal and cardiovascular injury and repair. Many of these subpopulations of macrophages remain uncharacterized. We have generated the Red FIRE rat, which is a cross between the Csf1r-mApple reporter rat and the super-enhancer FIRE knockout rat. The Csf1r-mApple reporter rat introduces a fluorescent signal to cells of the monocyte-macrophage lineage and the KO of FIRE (fms-intronic regulatory element), while the FIRE rat has fms-intronic regulatory element (FIRE), which is the superenhancer in the Csf1r locus knocked out, resulting in depletion of tissue resident macrophages. These red FIRE rats will allow us to visualize all Csf1r expressing cells (macrophages) and in the FIRE rats deplete populations of tissue resident macrophages (TRM) (including those in the kidney and heart). This will enable us to visualize and study TRM populations in homeostasis and injury. We hypothesise that the red FIRE rats will show a more severe phenotype in injury and have altered vascular function (local and systemic). Male and female (8–10-week-old) rats underwent a 6- or 12-week 5/6 subtotal nephrectomy (5/6 STNx) in groups of 4-8. Baseline, midpoint and endpoint urine and serum were collected for analysis, as well as blood pressure measurements and echocardiograms to monitor kidney and heart health/decline. At the end of the experiment, kidneys and the heart were collected for flow cytometry, immunofluorescence, RT-qPCR, and histological staining. The thoracic aorta, mesentery, and common renal arteries were collected for functional analysis using isometric (wire)myography. The knockout of the FIRE super enhancer resulted in depletion of kidney TRMs (Fig. 1) as visualised by immunofluorescent staining of both wild type and macrophage-depleted (red FIRE) rat tissue. Figure 1A shows the composite image and individual stains; DAPI, IBa1 (pan macrophage marker), and Csf1r-mApple (tissue resident macrophages) on a naïve heart. Representative composite images also compare STNx hearts (Fig. 1B) and kidneys (Fig. 1C) in both wild type and macrophage-depleted rats. This allowed for comparison of these rats in both injury and homeostasis. Figure 1: Immunofluorescent staining of the uninjured heart of a FIRE wild type (WT), mApple positive rat (A), the injured kidney (B) and heart (C) of mApple positive, FIRE wild type (Control) or mApple positive, FIRE knock out (FIRE) rats post 12-week 5/6 subtotal nephrectomy (5/6 STNx). DAPI: nuclei, IBa1: all macrophages, csf1r (mApple): tissue resident macrophages. Representative imagining, figure made using FIJI. Our preliminary data suggests previously undescribed roles for tissue-resident macrophages in rats i.e. ion handling, vascular homeostasis and roles in CKD and repair. These results could help reveal new specific druggable targets that could be exploited for treatments which could halt progression of disease and thus reduce end stage renal failure patient numbers, healthcare costs and premature CVD-related deaths.

Snuffbox distal transradial access (dTRA) for arteriovenous fistuloplasty in Singapore: Going distal is safe.

Arteriovenous fistula (AVF) dysfunction resulting from stenosis or occlusion, is a prevalent issue in end-stage renal failure patients reliant on autogenous AVFs for dialysis. Recently, a distal transradial approach (dTRA) has emerged, offering advantages such as diminished access site complications, better patient comfort and reduced risk of radial artery occlusion. Our study seeks to assess the effectiveness, outcomes and complication rates of employing dTRA for arteriovenous fistuloplasty in Singaporean patients. A retrospective review of all dTRA fistuloplasties performed on dysfunctional or slow to mature AVFs from 2017 to 2023 in our institution was performed. Patients with a distal radial artery measuring 2 mm or more with no evidence of occlusion or thrombosis were included. Patients who required central venoplasty or cutting balloon angioplasty were excluded. Outcome measures included technical success, mean procedure duration, complications and post-intervention primary patency at 1, 3 and 6 months. Patients were followed up for 12 months post-intervention. A total of 37 patients were included. 97.3% of patients undergoing dTRA fistuloplasty had radiocephalic fistulas while 2.7% had brachiobasilic fistulas. There was 100% technical success (defined as success in radial artery cannulation, sheath insertion and crossing of stenotic lesions) in our study as all patients successfully underwent fistuloplasty via dTRA approach. One-month patency rate was 97.4%, 3-month patency rate was 92.1% and 6-month patency rate was 86.8%. There were no immediate complications (haematoma, infection, bleeding, pseudoaneurysm, occlusion) of the radial artery post-intervention. Our paper illustrates the safety and efficacy of utilising dTRA for arteriovenous fistuloplasty. This approach offers distinct benefits in addressing non-mature or dysfunctional distal forearm arteriovenous fistulas and should be taken into account in anatomically suitable cases.

Red cells from end-stage renal failure patients are less deformable, irrespective of the presence of anemia

Red cells from end-stage renal failure patients are less deformable, irrespective of the presence of anemia

An assessment of spiral flow graft patency rates in Hemodialysis (HD) patients

IntroductionVascular access for hemodialysis remains a challenge for end stage renal failure (ESRF) patients. Autogenous arterio-venous fistulae are the first choice, but synthetic grafts may be required. The Spiral Flow™ graft (SF) mimics physiological blood flow to minimize turbulence and neointimal hyperplasia. We analyzed patency of SF for hemodialysis at a vascular unit in Johannesburg, South Africa. MethodA retrospective review was performed of upper arm SF implanted between 2013and 2015. Primary and secondary patency rates were analyzed. ResultsEighty grafts were placed in 71 patients. The primary and secondary patency rates at 1 year were 54 % (95 % CI: 41 %-65 %) and 63 % (95 % CI: 43 %-78 %), respectively. Poor patency risks such as Black ethnicity, hypertension, diabetes and HIV, were present in 75 %, 61 %, 26 % and 19 %, respectively. ConclusionSFs were associated with acceptable patency rates in ESRF patients. Excessive comorbidities may affect patency rates.

Inferring personal intake recommendations of phosphorous and potassium for end-stage renal failure patients by simulating with Bayesian hierarchical multivariate model.

Most end-stage renal disease (ESRD) patients face a risk of malnutrition, partly due to dietary restrictions on phosphorous and, in some cases, potassium intake. These restrictions aim to regulate plasma phosphate and potassium concentrations and prevent the adverse effects of hyperphosphatemia or hyperkalemia. However, individual responses to nutrition are known to vary, highlighting the need for personalized recommendations rather than relying solely on general guidelines. In this study, our objective was to develop a Bayesian hierarchical multivariate model that estimates the individual effects of nutrients on plasma concentrations and to present a recommendation algorithm that utilizes this model to infer personalized dietary intakes capable of achieving normal ranges for all considered concentrations. Considering the limited research on the reactions of ESRD patients, we collected dietary intake data and corresponding laboratory analyses from a cohort of 37 patients. The collected data were used to estimate the common hierarchical model, from which personalized models of the patients' diets and individual reactions were extracted. The application of our recommendation algorithm revealed substantial variations in phosphorus and potassium intakes recommended for each patient. These personalized recommendations deviate from the general guidelines, suggesting that a notably richer diet may be proposed for certain patients to mitigate the risk of malnutrition. Furthermore, all the participants underwent either hospital, home, or peritoneal dialysis treatments. We explored the impact of treatment type on nutritional reactions by incorporating it as a nested level in the hierarchical model. Remarkably, this incorporation improved the fit of the nutritional effect model by a notable reduction in the normalized root mean square error (NRMSE) from 0.078 to 0.003. These findings highlight the potential for personalized dietary modifications to optimize nutritional status, enhance patient outcomes, and mitigate the risk of malnutrition in the ESRD population.

Percutaneous Transluminal Angioplasty (PTA) and Stent Implantation in Hemodialysis Patients with Central Venous Stenosis:A Study of Outcomes

BACKGROUND: Central venous stenosis and occlusion are serious complications that can arise from central venous catheterization in hemodialysis patients, leading to significant difficulties in the dialysis process. Common clinical manifestations include swelling in the arm or neck on the affected side and compromised hemodialysis access. To address this issue, percutaneous balloon angioplasty and stent implantation have emerged as potential solutions to maintain vein patency. However, there is a need to evaluate the efficacy of these interventions over an extended period to determine their long-term benefits. This study aimed to monitor the patency status periodically, starting at 1st Month, followed by assessments at 3rd Month, 6th Month, and finally, the 12th Month. METHODS: This single-center observational study focused on endovascular interventions performed on hemodialysis patients with central venous stenosis or occlusion.Participants included end-stage renal failure patients undergoing hemodialysis who exhibited clinical signs of central venous stenosis or occlusion. Data were collected from 60 patients, consisting of 42 males (70%) and 18 females (30%), with an average age of 46.19±13.21 years. The affected sites of central vein stenosis or occlusion were distributed as follows: 13 cases in the innominate veins, 25 cases in the superior vena cava, 18 cases in the brachiocephalic vein, and 10 cases in the subclavian vein. Some patients had multiple site occlusions, while others experienced occlusion of AV fistula. RESULTS: Of the 60 endovascular procedures performed, only one case did not achieve technical success, resulting in an overall success rate of 96.4%. Stent implantation was carried out in only four patients. No significant procedure-related complications were encountered, and all patients were able to undergo hemodialysis after the initial intervention. The primary patency rates for PTA at 1, 3, 6, and 12 months were 96%, 92%, 88%, and 86%, respectively. As for stent implantation, the primary patency rates at 1, 3, 6, and 12 months were 100%, 98%, 98%, and 98%, respectively. Assisted primary patency rates for PTA at 1, 3, 6, and 12 months were 2%, 6%, 11%, and 14%, respectively. During the 12-month follow-up, 10 reinterventions were performed, with three patients requiring more than two reinterventions. CONCLUSION: The study's findings demonstrate that endovascular interventions, such as percutaneous balloon angioplasty and stent implantation, are highly effective in managing central venous stenosis or occlusion in hemodialysis patients. These interventions showed a remarkable success rate and a minimal occurrence of procedure-related complications. Particularly, stent implantation consistently exhibited 100% primary patency at all evaluated time points. While the assisted primary patency rates for PTA were relatively lower, the overall need for reinterventions remained low, emphasizing the long-term benefits of these procedures. Based on these promising results, endovascular interventions can be considered as a viable and efficient option for the management of central venous stenosis or occlusion in hemodialysis patients, offering improved hemodialysis access and ensuring enhanced patient outcomes.

A case report of gabapentin induced jaw myoclonus in end stage renal failure patient

A case report of gabapentin induced jaw myoclonus in end stage renal failure patient

Is there correlation between flow volume and Kt/V ratio in upper arm arteriovenous fistula in patients end stage renal failure?

Introduction: Chronic kidney disease is irreversible and may result in end-stage renal failure (ESRF). The kidney replacement program is determined by calculating Kt/V ratios, one of the dialysis efficiency indicators in treatment planning in routine dialysis applications in ESRF patients. We aimed to investigate whether there is a correlation between flow rate and Kt/V ratio. Methods: All patients were evaluated by B-mode ultrasonography (US) and color doppler ultrasonography (CDUS). The anastomosis line diameter was measured in the B-mode US. The fistula flow rate was calculated in a spectral examination at the anatomical location where the fistulized flow was best obtained at the anastomosis level. Patients with a fistula flow rate above 300 mL/min in CDUS examinations were considered reasonable flow rates. The fistula flow rate in these patients was compared with the Kt/V ratios. Spearman’s rank correlation coefficient was calculated since the normal distribution condition was not met to determine the relationship between variables. Results: The results of this study showed a high level (r=0.72, P=0.001) of positive and statistically significant correlation between flow rate and Kt/V ratio in upper arm arteriovenous fistula in patients with end stage renal failure. Conclusion: We found a highly positive and statistically significant correlation between fistula flow rate and Kt/V ratio. Low Kt/V ratios have different causes. Low fistula flow should be considered first in low Kt/V values.

Segmental bioimpedance in pregnant end stage renal failure patient for dry weight titration and volume management (case report)

BackgroundVolume assessment, dry weight titration, and blood pressure control in pregnant kidney failure patients are often challenging, with physiological fluid accumulation in the trunk and lower limbs and an increased risk of preeclampsia. We used segmental bioimpedance in the volume management of our kidney failure patient on haemodialysis.Case presentationWe report a case of a female patient on maintenance haemodiafiltration with no residual kidney function for whom we used segmental bioimpedance to guide dry weight adjustment. At different gestational periods, we targeted a different extracellular to total body water ratio according to body segments. This allowed us to support her high-risk pregnancy, identify her as probably developing preeclampsia and trigger a plan for closer monitoring and delivery during the third trimester when she had rapid weight gain.ConclusionSegmental bioimpedance is a practical, simple, and non-invasive test that can be performed at the dialysis unit and is useful as an adjunct decision-making tool in the management of pregnant dialysis patients.

Ultrasonographic changes of the median nerve in patients with end-stage renal failure and comparing it with a control group

Carpal Tunnel Syndrome (CTS) is characterized by median nerve entrapment in the wrist. CTS is diagnosed by clinical symptoms, which are confirmed by electrodiagnostic studies. This study aimed to assess median nerve cross-sectional area and elastography in chronic hemodialysis patients. This case-control study was conducted on end-stage renal failure (ESRD) patients undergoing hemodialysis at Rasool Akram Hospital's Dialysis Unit. The healthy companions of the patients were included as control group. An experienced rheumatologist used a supersonic device with linear array probes and dynamic scanners (5-22 MHz) to perform the sonography. The current study was conducted on both hands. There was no statistically significant difference between 30 patients and 30 healthy individuals regarding age, weight, and body mass index. The cross sectional area of median nerve in both hands was increased in the dialysis group compared to the control group. However, it was significantly higher in the patient group's right hand than in the control group (P = 0.031). Considering the causes of ESRD and parathormone levels, the cross-sectional area and mean right and left median nerve elastography were not different between the two groups. The results showed that the patient group had a larger right and left median nerve cross-sectional area than the control group. However, the median nerve elastographic indices did not differ between dialysis patients and healthy individuals.

Simultaneous pancreas-kidney transplantation for end-stage renal failure in type 1 diabetes mellitus: Current perspectives.

Type 1 diabetes mellitus (T1DM) is one of the important causes of chronic kidney disease (CKD) and end-stage renal failure (ESRF). Even with the best available treatment options, management of T1DM poses significant challenges for cli nicians across the world, especially when associated with CKD and ESRF. Substantial increases in morbidity and mortality along with marked rise in treatment costs and marked reduction of quality of life are the usual consequences of onset of CKD and progression to ESRF in patients with T1DM. Simultaneous pancreas-kidney transplant (SPK) is an attractive and promising treatment option for patients with advanced CKD/ESRF and T1DM for potential cure of these diseases and possibly several complications. However, limited availability of the organs for transplantation, the need for long-term immunosuppression to prevent rejection, peri- and post-operative complications of SPK, lack of resources and the expertise for the procedure in many centers, and the cost implications related to the surgery and postoperative care of these patients are major issues faced by clinicians across the globe. This clinical update review compiles the latest evidence and current recommendations of SPK for patients with T1DM and advanced CKD/ESRF to enable clinicians to care for these diseases.

A rare case of an aortic arch stent causing central vein stenosis

Purpose Central vein stenosis is commonly encountered in end stage renal disease patients on hemodialysis. Most are manageable with repeated procedures and venoplasty, however in some cases, venoplasty may not be successful. Method We discuss a rare case of persistent upper limb swelling due to severe central vein stenosis from compression of an aortic arch stent. Result Despite attempt at prolonged balloon inflation during venoplasty of the central vein, the stenosis still persisted. The arteriovenous fistula was then ligated and other forms of vascular access for hemodialysis were sought after. Conclusion Central venograms may be useful in end stage renal failure patients as part of pre-operative arteriovenous fistula creation so as to anticipate the possibility of central vein stenosis and its associated complications.

The diurnal change of thyroid-stimulating hormone and the effect of this change on thyroid functions in patients with chronic kidney disease.

Thyroid-stimulating hormone (TSH) has a pulsatile and circadian rhythm in healthy individuals. We aimed to evaluate the diurnal changes of free thyroid hormones and serum TSH levels in patients with end-stage renal failure (ESRF) whose thyroidal functions are at normal ranges. Thirty hemodialysis patients with chronic renal failure and without a known thyroidal disease who are over 18 and 35 healthy individuals were included. The serum TSH, free T3, and free T4 levels were examined among the patient and control group which were taken at 8:00 a.m., 4:00 p.m., and 0:00 a.m. Twenty-two (73.3%) patients were male, and the mean age of the patient group was 64 (sd = 14.45 years). Seventeen (48.6%) of the control group were female, and the mean age was 31.9 (sd = 6.4 years). Serum free T3 levels, measured at three different time points (8:00 a.m., 4:00 p.m., and 0:00 a.m.), were significantly lower in the patient group than in the control group and serum free T4 levels were measured at three different time points (8:00 am, 4:00 p.m., and 0:00 a.m.) were significantly higher in the patient group than in the control group. Serum TSH levels were higher in the patient group than in the control group at 08:00, and were lower at 24:00 (p < 0.001). The nocturnal increase of serum TSH level under 0.525 suggested diurnal rhythm disruption with 83% sensitivity and 87% specificity. The nocturnal serum TSH increase is not seen in ESRF patients who did not have a thyroid disease. We think that not observing a nocturnal TSH increase could be an early indication of the sick euthyroid syndrome.

Role of Erythropoietin In Pre-Renal Transplant Patients Undergoing Oral Surgical Procedures-Two Case Reports

The Oral Cavity Is Often Called The "Gateway To The Body," Dentist As The "Gatekeepers Of Health." Chronic Kidney Disease Is An Emerging Disease With Increased Mortality In A Low Resource Setting, According To The Global Disease Burden Report (2015)1 Lack Of Infrastructure And Awareness Among The Public Is Diagnosed At A Late Stage, Leading To Increased Mortality. In A Parallel Line, Dentistry In Developing Countries Still Is An Alien Entity To The Rural And Suburban Areas. End-Stage Renal Failure Patients Who Were Advised For Renal Transplants Visit The Dentist With Poor Oral Hygiene And Foci Of Infection, Which Must Be Eliminated. Anemia In End Stage Renal Disease And Its Management Is Challenging For The Clinicians With The Lack Of Erythropoietin Hormone Exposes The Patients To Risk Of Fatigue, Breathlessness, Lower Quality Of Life And Blood Transfusion2, 3.From Early 1980’s Erythropoesis Stimulating Agents Were Used In Kidney Damaged Patients Undergoing Dialysis But Their Application In Oral Maxillofacial Surgery Was Scarce To Minimize Morbidity And To Avoid Blood Transfusion4-6.&#x0D; Keywords: Oral Cavity, Chronic Kidney Disease, Dentistry, Oral Hygiene

Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study.

Hyperphosphatemia remains a major complication in patients with Continuous ambulatory peritoneal dialysis (CAPD) leading to increased morbidity and mortality. However, phosphorus management still has many challenges. This study aimed to investigate the prevalence and factors of hyperphosphatemia among continuous ambulatory peritoneal dialysis patients in a tertiary public hospital in Shanghai, China. The single-center cross-sectional study recruited end-stage renal failure patients who received continuous ambulatory peritoneal dialysis (CAPD) for at least 3 months. The participants aged 18-80 years had undergone CAPD between 1 July 2021 and 30 May 2022, in Shanghai, China.The patients' sociodemographic, clinical, and laboratory data were collected prospectively from medical records and via face-to-face interviews. A sample size of convenience decides the sample size. This study used the information-motivation-behavioral (IMB) skills model as a theoretical framework. The questionnaire included knowledge and behavior of diet and medication in patients with hyperphosphatemia of chronic kidney disease, self-efficacy for managing chronic disease, and social support rating scale. Univariate analysis and binary logistic regression were performed to identify the influencing factors of hyperphosphatemia by SPPS 27.0. In total, 141 CAPD patients (73% hyperphosphatemia) were included in the final analysis. In logistic regression analysis, dialysis vintage (OR: 0.975, 95%CI: 0.957-0.993), dialysis exchanges (OR: 0.317, 95%CI: 0.131-0.768), urine output (OR: 0.997, 95%CI: 0.995-0.999), serum albumin (OR: 1.166, 95%CI:1.008-1.349), serum creatinine (OR: 1.005, 95%CI: 1.001-1.008), hyperphosphatemia knowledge behavior score (OR: 0.888, 95%CI: 0.797-0.991), and social support level (OR: 0.841, 95%CI:0.765-0.925) were the influencing factors of hyperphosphatemia. Hyperphosphatemia is a frequent complication in CAPD patients. Dialysis vintage, dialysis exchanges, urine output, serum albumin, serum creatinine, hyperphosphatemia knowledge behavior, and social support were the associated factors of hyperphosphatemia in CAPD patients. It is crucial for healthcare providers to maintain phosphorus balance among CAPD patients using phosphorus management strategies.

Unraveling the Secrets Behind the Multidrug-Resistant Tuberculosis Treatment Outcome in Chronic Renal Failure Patients Requiring Hemodialysis: A Systematic Review.

Multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR TB) is a global concern, with 450,000 new cases and 191,000 deaths in 2021. TB and chronic kidney disease (CKD) have been associated since 1974, with suggested explanations such as oxidative stress, malnutrition, dysfunction in vitamin D metabolism, and a compromised cell-mediated immune response. End-stage renal failure patients are more likely to acquire drug resistance due to poor adherence, adverse drug reactions, and inappropriate dose adjustment. We then aim to evaluate the therapeutic outcome of multidrug-resistant TB of the lungs in patients who require hemodialysis in terms of successful treatment (cured and treatment completed) and the associated factors for a favorable outcome. Our secondary goal is to identify unfavorable treatment outcomes (treatment failed, patient died, or patient lost to follow-up) and the underlying associated factors. We conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Guidelines for this systematic review. We included adults (>19 years old) with chronic kidney disease who needed hemodialysis and had microbiologically confirmed multidrug-resistant pulmonary TB, excluding patients who had a renal allograft transplant, were on peritoneal dialysis, hadextrapulmonary TB, were childrenand pregnant patients. We searched PubMed, MEDLINE, PubMed Central, ScienceDirect, Public Library of Science (PLOS), and Google Scholar. Keywords were combined with the Boolean "AND" operator to gather results as well as the medical subject heading (MeSH) search strategy. After screening study articles by reading their titles and abstracts, the following tools were used to assess the risk of bias: the Newcastle-Ottawa scale for observational studies, the Assessment of Multiple Systematic Reviews (AMSTAR) checklist for systematic reviews, and the Joanna Briggs Institute (JBI) assessment tool for case reports.Primary and secondary outcomes were assessed, and a conclusion was made. We gathered 21,570 studies from the databases between 2013 and 2023, with 30,062 total participants. There were eight eligible studies for review. Patients with CKD, particularly those on dialysis, are at increased risk of TB due to a combination of factors that contribute to immunosuppression. TB reactivation is common in chronic renal failure patients. Diagnostic samples such as sputum and pleural fluid had lower sensitivity rates compared to tissue samples, which led to delays in diagnosis and treatment and, most importantly, contributed to drug resistance. All new dialysis patients should undergo interferon-gamma release assay testing. TB-infected patients with severe renal disease (eGFR 30 ml/min) had increased morbidity and mortality; however, the use of directly observed treatment, short-course (DOTS), and renal-dose adjustment of anti-TB medications significantly reduced these risks. Drug-induced hepatitis and cutaneous reactions were common adverse effects of anti-TB medications. A therapeutic drug monitoring guideline is required to reduce these adverse events and even mortality. Additional research is required to assess the safety and efficacy of therapeutic regimens, as well as their outcomes, in this population with multidrug-resistant TB.

Arteriovenous fistula is associated with diastolic dysfunction in end-stage renal failure patients

Arteriovenous fistula is associated with diastolic dysfunction in end-stage renal failure patients

Effect of Hemodialysis Duration on Urea Reduction Ratio and KT/V Target among End-Stage Renal Failure Patients

Effect of Hemodialysis Duration on Urea Reduction Ratio and KT/V Target among End-Stage Renal Failure Patients

Study of Post-Kidney Transplantation Parietal Complications and Presarcopenia

Sarcopenia is defined as a loss of muscle mass and strength. Its effects on postoperative outcomes in oncology and geriatrics have already been shown. Approximately 40% of patients in end-stage renal failure are affected with sarcopenia. A recent study suggests that sarcopenia could predict surgical complications after renal transplantation in obese patients. The aim of this study was to evaluate the effect of sarcopenia on parietal complications (eg, wound healing, lymphocele, hematoma). Two indices of muscle fat infiltration (intra-muscular adipose content [IMAC], Hounsfield unit average calculation [HUAC]) and 3 of muscle mass index (total psoas index [TPI], visceral fat area/total abdominal muscle area [VFA/TAMA], and skeletal muscle mass index [SMMI]) were retrospectively measured on pretransplant computed tomography scans for patients undergoing kidney transplantation between 2007 and 2017. Patients were considered sarcopenic when the index was above the third quartile for muscle fat infiltration (IMAC, HUAC) and VFA/TAMA, and under the first quartile for muscle mass (TPI, SMMI). The occurrence of wound healing, collection (hematoma and lymphocele), and acute rejection were compared between sarcopenic and nonsarcopenic patients. Of 484 transplanted patients, 117 patients had a computed tomography scan before transplantation. Patients with a high HUAC had significantly more collections (P=.02) and total parietal complications (P=.09). Patients with a high IMAC had significantly more acute rejection (P=.001). Muscle fat infiltration appears to influence the outcome of renal transplantation. The management of sarcopenia in pretransplantation should be a subject of further research.

Quality of Life Assessment in Patients of Stage V Chronic Kidney Disease

Introduction: Despite ongoing advances in the treatment of chronic kidney disease (CKD), the mortality rate, and level of health-related quality of life (HRQOL) for the CKD population remain significantly higher than for the general population. The importance of measuring end-stage renal failure (ESRF) patients' quality of life in relation to healthcare lies in not only providing absolute survival but also the quality of that survival. Due to cost constraints, the profile of chronic kidney disease patients and their treatment in Bangladesh is almost identical to that of India, with patients frequently requesting a reduction in the frequency of dialysis sessions, the use of less expensive dialyzers, dialyzer reuse, and the absence of erythropoietin therapy. Hence, augmenting the QOL may perhaps be a challenge and an observable fact of specific interest for renal healthcare teams. This study is intended to assess KDQOL among patients receiving hemodialysis for 8 hours, and 12 hours per week, patients receiving CAPD, and patients of CKD stage V who decline any form of renal replacement therapy, and remained on conservative treatment. The aim of the study was to assess the quality of life among patients of CKD Stage V. Methods: This cross-sectional study was carried out at the Department of Nephrology, Dhaka Medical College Hospital and BIRDEM general hospital. The patients who received consultation at the Outdoor Department of selected hospital from November 2010 to October 2011. The study assess the of Quality of Life, and Cost Effectiveness on different modalities of treatment among the patients of chronic kidney disease stage V, and also to find out the best modality of dialysis. A total number of 134 consecutive patients were enrolled in this study, out of which 42 patients who were advised to commence renal replacement therapy, and after counseling opted to remain in conservative treatment were considered as GROUP I, 39 patients who received hemodialysis 8 hours per week were considered as GROUP II, 30 patients who received hemodialysis 12 hours per week in one or more centers were considered as GROUP III, and 23 patients who received Continuous Peritoneal Dialysis at least 3 exchanges per day were considered as GROUP IV. Result: Mean age was almost similar in all four groups, and most of the patients were 5th decade, and above. Male was predominant in all four groups, and the male-female ratio was almost 2:1 in the whole study patients. Diabetic nephropathy and glomerulonephritis were more common etiology of CKD in all four groups. Monthly expenditure was significantly (p&lt;0.05) higher in group IV, followed by group III, group II, and group I in all three follow-ups, however, monthly expenditure was almost similar between group III, and group IV (p&gt;0.05) but the mean monthly expenditure was higher in group IV patients. Mean serum Creatinine was lowest in group IV followed by group III, group II, and group I in descending order. Serum albumin was low in all the groups but almost parallel in all follow-ups in group II, groups I, and group IV, whereas the lowest was in group II followed by group I and group IV, but declined in group III during the 2nd, and 3rd follow-up from 1st follow-up. Hemoglobin level consistently remained within the target range in group IV in all follow-ups but below the target range in group I followed by group II, and group III in ascending order. The physical component score increased significantly in Group III, and Group IV at consecutive follow-ups, however, it was higher in Group IV. Similarly, the mental component score was recorded highest in Group IV, followed by group III, group II, and group I. Regarding mortality, it was observed that more than half of the patients were expired in group I, one-third in group II, and 16.7% in group III, and only 8.7% in group IV during final follow-up. Conclusion: Patients receiving continuous ambulatory peritoneal dialysis achieved the best clinical parameters in terms of control of blood pressure, and volume overload. On the other hand, parameters were a lot away from the desired target in patients receiving hemodialysis for 8 hours per week, and they did not have significantly better parameters in comparison to those who were only on conservative treatment. The scenario of serum albumin, and serum creatinine, though complicated by the existence of malnutrition, were in best approximation to the desired level in these patients. According to the age-sex-matched risk categorization of the patients, it was found that the majority of patients on conservative treatment were in more than the average risk category.